x

Armata Pharmaceuticals, Inc. (NYSE:ARMP)

Health Care/Life Sciences • Biotechnology
CIK 921114
Company

Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, which focuses on the development of bacteriophage therapeutics for the treatment of drug-resistant bacterial infections. The company was founded on May 9, 2019 and is headquartered in Los Angeles, CA.

Address
4503 Glencoe Avenue
Marina del Rey
Los Angeles, California 90292
Employees
75
Stock Info
Close
$4.12
Day Range
3.70 - 4.00
52 Week Range
1.07 - 5.26
Average volume
19.69K
Short Interest
43.45K (02/15/24)
% of Float Shorted
0.40%
Market Cap
$148.92M
Revenue
$5.51M
Net Income
-$36.92M
2020 Sales Growth
N/A
Rev. per Employee
$54.03K
P/E Ratio
N/A
EPS
-$1.65
Yield
N/A
Dividend
N/A
Ex-Dividend Date
N/A
Key Executives
Board Of Directors
Chief Executive Officer & Director
Deborah L Birx MD
Chairman
Robin C Kramer CPA
Independent Director
Jules Haimovitz
Independent Director
Todd C Peterson PhD
Independent Director
Sarah J Schlesinger MD
Independent Director
Odysseas Demosthenes Kostas MD
Independent Director
Joseph M Patti PhD
SEC filings
DateFormEvent
19 Dec, 2024 8-K
4 Dec, 2024 8-K
15 Nov, 2024 8-K
14 Nov, 2024 SC 13D/A
13 Nov, 2024 8-K
13 Nov, 2024 10-Q
12 Nov, 2024 8-K
3 Oct, 2024 8-K
3 Oct, 2024 4
26 Sep, 2024 8-K
26 Aug, 2024 8-K
19 Aug, 2024 3
15 Aug, 2024 8-K
13 Aug, 2024 10-Q
13 Aug, 2024 8-K
25 Jul, 2024 8-K
28 Jun, 2024 3
14 Jun, 2024 8-K
7 May, 2024 8-K
7 May, 2024 10-Q
29 Apr, 2024 DEF 14A
29 Apr, 2024 ARS
22 Mar, 2024 8-K
21 Mar, 2024 8-K
21 Mar, 2024 10-K
18 Mar, 2024 4
18 Mar, 2024 4
18 Mar, 2024 4
18 Mar, 2024 4
18 Mar, 2024 4
18 Mar, 2024 4
18 Mar, 2024 4
18 Mar, 2024 4
4 Mar, 2024 8-K
4 Mar, 2024 SC 13D/A
23 Jan, 2024 S-8
26 Dec, 2023 4
26 Dec, 2023 4
26 Dec, 2023 4
26 Dec, 2023 4
26 Dec, 2023 4
26 Dec, 2023 4
26 Dec, 2023 4
26 Dec, 2023 4
15 Nov, 2023 S-8
14 Nov, 2023 8-K
14 Nov, 2023 10-Q
13 Nov, 2023 UPLOAD
7 Nov, 2023 CORRESP
26 Oct, 2023 UPLOAD
22 Sep, 2023 3
20 Sep, 2023 8-K
14 Aug, 2023 8-K
14 Aug, 2023 10-Q
3 Aug, 2023 DEF 14A
3 Aug, 2023 ARS
3 Aug, 2023 DEFA14A
24 Jul, 2023 PRE 14A
19 Jul, 2023 3
19 Jul, 2023 8-K
11 Jul, 2023 SC 13D/A
11 Jul, 2023 8-K CEO Change
27 Jun, 2023 8-K
12 May, 2023 8-K
11 May, 2023 10-Q
8 May, 2023 3
5 May, 2023 8-K
6 Apr, 2023 EFFECT
6 Apr, 2023 424B3
5 Apr, 2023 CORRESP
28 Mar, 2023 S-3/A
16 Mar, 2023 10-K
16 Mar, 2023 8-K
6 Mar, 2023 8-K
17 Feb, 2023 UPLOAD
13 Feb, 2023 S-3
7 Feb, 2023 3
12 Jan, 2023 4
10 Jan, 2023 SC 13D/A
10 Jan, 2023 8-K
19 Dec, 2022 8-K
18 Nov, 2022 8-K
9 Nov, 2022 8-K
9 Nov, 2022 10-Q
17 Oct, 2022 DEF 14A
20 Sep, 2022 8-K
11 Aug, 2022 10-Q
11 Aug, 2022 8-K
1 Jun, 2022 424B3
31 May, 2022 EFFECT
26 May, 2022 CORRESP
24 May, 2022 S-3/A
19 May, 2022 UPLOAD
16 May, 2022 S-3
12 May, 2022 10-Q
15 Apr, 2022 4
15 Apr, 2022 4
15 Apr, 2022 4
15 Apr, 2022 4
15 Apr, 2022 4
15 Apr, 2022 4
15 Apr, 2022 4
15 Apr, 2022 4
15 Apr, 2022 4
6 Apr, 2022 EFFECT
6 Apr, 2022 424B3
5 Apr, 2022 CORRESP
1 Apr, 2022 SC 13D/A
1 Apr, 2022 UPLOAD
1 Apr, 2022 4
31 Mar, 2022 8-K
29 Mar, 2022 S-3
28 Mar, 2022 8-K
17 Mar, 2022 10-K
9 Mar, 2022 DEF 14A
24 Feb, 2022 PRE 14A
11 Feb, 2022 4
11 Feb, 2022 SC 13D/A
11 Feb, 2022 8-K
5 Jan, 2022 8-K
10 Nov, 2021 10-Q
2 Nov, 2021 8-K
1 Nov, 2021 SC 13D/A
1 Nov, 2021 4
29 Oct, 2021 8-K
13 Aug, 2021 8-K
12 Aug, 2021 10-Q
4 Aug, 2021 8-K CEO Change
3 Aug, 2021 4
14 Jun, 2021 8-K
9 Jun, 2021 4
9 Jun, 2021 4
9 Jun, 2021 4
9 Jun, 2021 4
9 Jun, 2021 4
20 May, 2021 EFFECT
20 May, 2021 424B3
18 May, 2021 UPLOAD
18 May, 2021 CORRESP
14 May, 2021 8-K
13 May, 2021 S-3
13 May, 2021 10-Q
22 Apr, 2021 DEFA14A
21 Apr, 2021 DEF 14A
5 Apr, 2021 8-K
5 Apr, 2021 3
5 Apr, 2021 4
5 Apr, 2021 SC 13D/A
26 Mar, 2021 4
26 Mar, 2021 4
26 Mar, 2021 4
26 Mar, 2021 4
18 Mar, 2021 10-K
17 Mar, 2021 4
17 Mar, 2021 SC 13D/A
17 Mar, 2021 8-K
26 Feb, 2021 DEF 14A
24 Feb, 2021 UPLOAD
22 Feb, 2021 CORRESP
19 Feb, 2021 UPLOAD
9 Feb, 2021 PRE 14A
28 Jan, 2021 4
27 Jan, 2021 8-K
27 Jan, 2021 SC 13D/A
6 Jan, 2021 8-K
Last update:2024-03-06 13:23:03.773660
Armata Pharmaceuticals, Inc. by TradingView

Sign Up to Subscribe